Certified by Founder Lodge
Candid Therapeutics
United States - San Diego, CA
START UP
1 Disclosed Funding Rounds $370,000,000
0 Participating Investments
-
Founded date
2024
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Clinical stage biotechnology company dedicated to advancing the treatment of a range of immunological conditions
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| September, 10 ,2024 | Unknown | $370,000,000 |
Foresite Capital
Qiming Venture Partners USA
Fidelity Investments
Vida Ventures, LLC
LS Polaris Innovation Fund
Soleus Capital Management, L.P.
Boxer Capital, LLC
Redmile Group
venBio
Samsara BioCapital
TCGX
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Helex | $3,500,000 | (Nov 4, 2025)
xMEMS | $21,000,000 | (Nov 4, 2025)
catalyx space | $5,400,000 | (Nov 4, 2025)
Cephia AI | $4,000,000 | (Nov 4, 2025)
Ornn | $5,700,000 | (Nov 4, 2025)
